| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819614 | Journal of Cystic Fibrosis | 2018 | 7 Pages |
Abstract
In this cohort of CF patients, mean ceftaroline half-life was 1.1Â h, which is notably lower than the general population. The dosing regimen studied, which exceeds the recommended dosing in the non-CF population, was adequate to achieve >Â 60% time above the MIC in all patients.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Emily E. Barsky, Luis M. Pereira, Keri J. Sullivan, Alanna Wong, Alexander J. McAdam, Gregory S. Sawicki, Gregory P. Priebe, Susan M. Goobie,